We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$135M
AUM Growth
+$5.13M
Cap. Flow
+$2.88M
Cap. Flow %
2.13%
Top 10 Hldgs %
22.44%
Holding
185
New
26
Increased
50
Reduced
55
Closed
31

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$1.2M
2
COST icon
Costco
COST
+$1.15M
3
AMGN icon
Amgen
AMGN
+$1.07M
4
DY icon
Dycom Industries
DY
+$931K
5
LOW icon
Lowe's Companies
LOW
+$899K

Sector Composition

Rank Sector Weight
1 Industrials 21.57%
2 Healthcare 18.97%
3 Financials 18.11%
4 Consumer Staples 13.07%
5 Technology 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.9M 4.36%
113,700
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$4.32M 3.19%
32,615
-525
-2% -$67K
WASH icon
3
Washington Trust Bancorp
WASH
$743M
$3.75M 2.78%
72,809
+4,550
+7% +$227K
GE icon
4
GE Aerospace
GE
$374B
$2.91M 2.16%
22,503
-276
-1% -$37.8K
KMB icon
5
Kimberly-Clark
KMB
$36.3B
$2.6M 1.92%
20,138
PFE icon
6
Pfizer
PFE
$143B
$2.36M 1.75%
74,045
+11,173
+18% +$352K
XOM icon
7
ExxonMobil
XOM
$644B
$2.2M 1.63%
27,298
-1,238
-4% -$101K
PRXL
8
DELISTED
Parexel International Corp
PRXL
$2.14M 1.59%
24,670
-1,850
-7% -$138K
CSCO icon
9
Cisco
CSCO
$457B
$2.08M 1.54%
66,397
-400
-0.6% -$13K
PB icon
10
Prosperity Bancshares
PB
$8.97B
$2.06M 1.53%
32,140
+7,050
+28% +$465K
INTC icon
11
Intel
INTC
$455B
$1.92M 1.42%
57,019
+6,680
+13% +$239K
INDB icon
12
Independent Bank
INDB
$3.99B
$1.92M 1.42%
28,790
+1,000
+4% +$63.7K
ZTS icon
13
Zoetis
ZTS
$32.4B
$1.84M 1.36%
29,518
+250
+0.9% +$14.8K
WFC icon
14
Wells Fargo
WFC
$261B
$1.74M 1.29%
31,460
-3,550
-10% -$190K
TFC icon
15
Truist Financial
TFC
$63.3B
$1.72M 1.27%
37,940
-650
-2% -$28.2K
AB icon
16
AllianceBernstein
AB
$3.43B
$1.72M 1.27%
72,528
-3,600
-5% -$80.6K
DIS icon
17
Walt Disney
DIS
$167B
$1.66M 1.22%
15,579
+775
+5% +$84.9K
BMY icon
18
Bristol-Myers Squibb
BMY
$133B
$1.61M 1.19%
28,892
+575
+2% +$31.3K
AMGN icon
19
Amgen
AMGN
$208B
$1.54M 1.14%
8,945
+6,600
+281% +$1.07M
AAPL icon
20
Apple
AAPL
$4.54T
$1.53M 1.14%
42,624
-1,168
-3% -$43.2K
IBM icon
21
IBM
IBM
$211B
$1.52M 1.12%
10,306
+3,975
+63% +$599K
ADI icon
22
Analog Devices
ADI
$179B
$1.48M 1.1%
19,017
+8,500
+81% +$675K
NKE icon
23
Nike
NKE
$61.9B
$1.46M 1.08%
24,725
+150
+0.6% +$8.09K
PNR icon
24
Pentair
PNR
$10.4B
$1.45M 1.07%
32,497
+1,749
+6% +$76.4K
CELG
25
DELISTED
Celgene Corp
CELG
$1.45M 1.07%
11,184
+1,234
+12% +$151K

Similar funds

New England Research & Management's Q2 2017 Portfolio in Review

As of Q2 2017, New England Research & Management held 185 positions worth $135M, up 3.9% from $130M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q2 2017 filing shows 26 new, 50 increased, 55 reduced and 31 closed positions. Its largest new stake was Norfolk Southern: 10,247 shares worth $1.25M. The largest sale was Toll Brothers, an estimated $1.28M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2017 buy was Norfolk Southern: 10,247 shares worth $1.25M.
  • New England Research & Management added most to Costco in Q2 2017, an estimated $1.15M increase.
  • New England Research & Management's biggest Q2 2017 reduction was CVS Health, cutting an estimated $910K.
  • New England Research & Management fully exited Toll Brothers in Q2 2017, selling an estimated $1.28M.
  • New England Research & Management's ten largest holdings make up 22% of its $135M portfolio in Q2 2017.
  • New England Research & Management opened 26 new positions and closed 31 in Q2 2017.
  • New England Research & Management's portfolio value rose 3.9% quarter-over-quarter to $135M.

Based on New England Research & Management's 13F filing for Q2 2017, filed 11 Jul 2017.